Otsuka reports expanded Phase IIIb results for Simtriyo in adult ADHD

Otsuka Pharmaceutical Development & Commercialisation and Otsuka Pharmaceutical have reported expanded Phase IIIb results for Simtriyo in adults with ADHD and comorbid anxiety disorders.

The post Otsuka reports expanded Phase IIIb results for Simtriyo in adult ADHD appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.